Report cover image

Global Sertraline Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 195 Pages
SKU # APRC20561965

Description

Summary

According to APO Research, The global Sertraline market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sertraline include Teva, Sun Pharmaceutical, Mylan, Pfizer, Torrent Pharmaceuticals, Oxford Pharma, Neurocon Inc, Lupin Pharmaceuticals and Lifecare Neuro, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sertraline, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sertraline, also provides the sales of main regions and countries. Of the upcoming market potential for Sertraline, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sertraline sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sertraline market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sertraline sales, projected growth trends, production technology, application and end-user industry.

Sertraline Segment by Company

Teva
Sun Pharmaceutical
Mylan
Pfizer
Torrent Pharmaceuticals
Oxford Pharma
Neurocon Inc
Lupin Pharmaceuticals
Lifecare Neuro
Healing Pharma India Pvt Ltd
Camber Pharmaceuticals
Aurobindo Pharma
APOTEX
Sertraline Segment by Type

Tablet
Oral Concentrate
Sertraline Segment by Application

Adult
Children
Sertraline Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sertraline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sertraline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sertraline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sertraline in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sertraline manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sertraline sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Sertraline Market by Type
1.2.1 Global Sertraline Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Oral Concentrate
1.3 Sertraline Market by Application
1.3.1 Global Sertraline Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Adult
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Sertraline Market Dynamics
2.1 Sertraline Industry Trends
2.2 Sertraline Industry Drivers
2.3 Sertraline Industry Opportunities and Challenges
2.4 Sertraline Industry Restraints
3 Global Market Growth Prospects
3.1 Global Sertraline Revenue Estimates and Forecasts (2020-2031)
3.2 Global Sertraline Revenue by Region
3.2.1 Global Sertraline Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Sertraline Revenue by Region (2020-2025)
3.2.3 Global Sertraline Revenue by Region (2026-2031)
3.2.4 Global Sertraline Revenue Market Share by Region (2020-2031)
3.3 Global Sertraline Sales Estimates and Forecasts 2020-2031
3.4 Global Sertraline Sales by Region
3.4.1 Global Sertraline Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Sertraline Sales by Region (2020-2025)
3.4.3 Global Sertraline Sales by Region (2026-2031)
3.4.4 Global Sertraline Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Sertraline Revenue by Manufacturers
4.1.1 Global Sertraline Revenue by Manufacturers (2020-2025)
4.1.2 Global Sertraline Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Sertraline Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Sertraline Sales by Manufacturers
4.2.1 Global Sertraline Sales by Manufacturers (2020-2025)
4.2.2 Global Sertraline Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Sertraline Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Sertraline Sales Price by Manufacturers (2020-2025)
4.4 Global Sertraline Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Sertraline Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Sertraline Manufacturers, Product Type & Application
4.7 Global Sertraline Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Sertraline Market CR5 and HHI
4.8.2 2024 Sertraline Tier 1, Tier 2, and Tier 3
5 Sertraline Market by Type
5.1 Global Sertraline Revenue by Type
5.1.1 Global Sertraline Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Sertraline Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Sertraline Revenue Market Share by Type (2020-2031)
5.2 Global Sertraline Sales by Type
5.2.1 Global Sertraline Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Sertraline Sales by Type (2020-2031) & (k units)
5.2.3 Global Sertraline Sales Market Share by Type (2020-2031)
5.3 Global Sertraline Price by Type
6 Sertraline Market by Application
6.1 Global Sertraline Revenue by Application
6.1.1 Global Sertraline Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Sertraline Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Sertraline Revenue Market Share by Application (2020-2031)
6.2 Global Sertraline Sales by Application
6.2.1 Global Sertraline Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Sertraline Sales by Application (2020-2031) & (k units)
6.2.3 Global Sertraline Sales Market Share by Application (2020-2031)
6.3 Global Sertraline Price by Application
7 Company Profiles
7.1 Teva
7.1.1 Teva Comapny Information
7.1.2 Teva Business Overview
7.1.3 Teva Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teva Sertraline Product Portfolio
7.1.5 Teva Recent Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Comapny Information
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sun Pharmaceutical Sertraline Product Portfolio
7.2.5 Sun Pharmaceutical Recent Developments
7.3 Mylan
7.3.1 Mylan Comapny Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Mylan Sertraline Product Portfolio
7.3.5 Mylan Recent Developments
7.4 Pfizer
7.4.1 Pfizer Comapny Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Pfizer Sertraline Product Portfolio
7.4.5 Pfizer Recent Developments
7.5 Torrent Pharmaceuticals
7.5.1 Torrent Pharmaceuticals Comapny Information
7.5.2 Torrent Pharmaceuticals Business Overview
7.5.3 Torrent Pharmaceuticals Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Torrent Pharmaceuticals Sertraline Product Portfolio
7.5.5 Torrent Pharmaceuticals Recent Developments
7.6 Oxford Pharma
7.6.1 Oxford Pharma Comapny Information
7.6.2 Oxford Pharma Business Overview
7.6.3 Oxford Pharma Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Oxford Pharma Sertraline Product Portfolio
7.6.5 Oxford Pharma Recent Developments
7.7 Neurocon Inc
7.7.1 Neurocon Inc Comapny Information
7.7.2 Neurocon Inc Business Overview
7.7.3 Neurocon Inc Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Neurocon Inc Sertraline Product Portfolio
7.7.5 Neurocon Inc Recent Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Comapny Information
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Lupin Pharmaceuticals Sertraline Product Portfolio
7.8.5 Lupin Pharmaceuticals Recent Developments
7.9 Lifecare Neuro
7.9.1 Lifecare Neuro Comapny Information
7.9.2 Lifecare Neuro Business Overview
7.9.3 Lifecare Neuro Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Lifecare Neuro Sertraline Product Portfolio
7.9.5 Lifecare Neuro Recent Developments
7.10 Healing Pharma India Pvt Ltd
7.10.1 Healing Pharma India Pvt Ltd Comapny Information
7.10.2 Healing Pharma India Pvt Ltd Business Overview
7.10.3 Healing Pharma India Pvt Ltd Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Healing Pharma India Pvt Ltd Sertraline Product Portfolio
7.10.5 Healing Pharma India Pvt Ltd Recent Developments
7.11 Camber Pharmaceuticals
7.11.1 Camber Pharmaceuticals Comapny Information
7.11.2 Camber Pharmaceuticals Business Overview
7.11.3 Camber Pharmaceuticals Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Camber Pharmaceuticals Sertraline Product Portfolio
7.11.5 Camber Pharmaceuticals Recent Developments
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Comapny Information
7.12.2 Aurobindo Pharma Business Overview
7.12.3 Aurobindo Pharma Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Aurobindo Pharma Sertraline Product Portfolio
7.12.5 Aurobindo Pharma Recent Developments
7.13 APOTEX
7.13.1 APOTEX Comapny Information
7.13.2 APOTEX Business Overview
7.13.3 APOTEX Sertraline Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 APOTEX Sertraline Product Portfolio
7.13.5 APOTEX Recent Developments
8 North America
8.1 North America Sertraline Market Size by Type
8.1.1 North America Sertraline Revenue by Type (2020-2031)
8.1.2 North America Sertraline Sales by Type (2020-2031)
8.1.3 North America Sertraline Price by Type (2020-2031)
8.2 North America Sertraline Market Size by Application
8.2.1 North America Sertraline Revenue by Application (2020-2031)
8.2.2 North America Sertraline Sales by Application (2020-2031)
8.2.3 North America Sertraline Price by Application (2020-2031)
8.3 North America Sertraline Market Size by Country
8.3.1 North America Sertraline Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Sertraline Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Sertraline Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Sertraline Market Size by Type
9.1.1 Europe Sertraline Revenue by Type (2020-2031)
9.1.2 Europe Sertraline Sales by Type (2020-2031)
9.1.3 Europe Sertraline Price by Type (2020-2031)
9.2 Europe Sertraline Market Size by Application
9.2.1 Europe Sertraline Revenue by Application (2020-2031)
9.2.2 Europe Sertraline Sales by Application (2020-2031)
9.2.3 Europe Sertraline Price by Application (2020-2031)
9.3 Europe Sertraline Market Size by Country
9.3.1 Europe Sertraline Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Sertraline Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Sertraline Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Sertraline Market Size by Type
10.1.1 China Sertraline Revenue by Type (2020-2031)
10.1.2 China Sertraline Sales by Type (2020-2031)
10.1.3 China Sertraline Price by Type (2020-2031)
10.2 China Sertraline Market Size by Application
10.2.1 China Sertraline Revenue by Application (2020-2031)
10.2.2 China Sertraline Sales by Application (2020-2031)
10.2.3 China Sertraline Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Sertraline Market Size by Type
11.1.1 Asia Sertraline Revenue by Type (2020-2031)
11.1.2 Asia Sertraline Sales by Type (2020-2031)
11.1.3 Asia Sertraline Price by Type (2020-2031)
11.2 Asia Sertraline Market Size by Application
11.2.1 Asia Sertraline Revenue by Application (2020-2031)
11.2.2 Asia Sertraline Sales by Application (2020-2031)
11.2.3 Asia Sertraline Price by Application (2020-2031)
11.3 Asia Sertraline Market Size by Country
11.3.1 Asia Sertraline Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Sertraline Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Sertraline Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Sertraline Market Size by Type
12.1.1 SAMEA Sertraline Revenue by Type (2020-2031)
12.1.2 SAMEA Sertraline Sales by Type (2020-2031)
12.1.3 SAMEA Sertraline Price by Type (2020-2031)
12.2 SAMEA Sertraline Market Size by Application
12.2.1 SAMEA Sertraline Revenue by Application (2020-2031)
12.2.2 SAMEA Sertraline Sales by Application (2020-2031)
12.2.3 SAMEA Sertraline Price by Application (2020-2031)
12.3 SAMEA Sertraline Market Size by Country
12.3.1 SAMEA Sertraline Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Sertraline Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Sertraline Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Sertraline Value Chain Analysis
13.1.1 Sertraline Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Sertraline Production Mode & Process
13.2 Sertraline Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Sertraline Distributors
13.2.3 Sertraline Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.